Lioré et Olivier

Meaningful AI for Independent Insurance Agencies

Retrieved on: 
Thursday, November 16, 2023
API, Business, Lioré et Olivier, Policy, Senior, Hope, Book of business (law), Partner, Partnership, CMO, Sales, Communications satellite

CANBY, Ore., Nov. 16, 2023 /PRNewswire/ -- Today, insurance agency platform HawkSoft and AI-powered insurtech LeO announce the integration of their products via HawkSoft's Partner API. LeO uses AI to guide independent insurance agents towards better prospect opportunities. In place of manually combing through leads in the hope of finding a good fit for your agency, LeO analyzes millions of data points to generate prospects lists that fit the profile of clients your agency is successful at serving. When combined with the wealth of client and policy data within an agency's HawkSoft Insurance Platform, LeO can generate prospect lists of top customers, cross-selling and win-back opportunities, and track upcoming renewals.

Key Points: 
  • LeO uses AI to guide independent insurance agents towards better prospect opportunities.
  • When combined with the wealth of client and policy data within an agency's HawkSoft Insurance Platform, LeO can generate prospect lists of top customers, cross-selling and win-back opportunities, and track upcoming renewals.
  • "We appear to be on the cusp of breakthrough AI innovation in the insurance world," observes Rushang Shah, CMO of HawkSoft.
  • Agencies that use LeO to power their prospecting, and HawkSoft to manage their agency data, can enable the integration in HawkSoft's Marketplace.

Six new leading technology and services providers join Vertafore Orange Partner Program

Retrieved on: 
Monday, March 21, 2022
Lioré et Olivier, Blockchain, Network, AFCO, MGA, Program, AI, Intelligence, Language, API, Artificial intelligence, Public employee pension plans in the United States, Technology, Industry, Machine learning, Architecture, Policy, AIM, Solution, Acceleration, Efficiency, Insurance, Video game, Risk management, Petroleum, Medical device, Sales

DENVER, March 21, 2022 /PRNewswire/ -- Vertafore®, the leader in modern insurance technology, today announced the addition of six solution providers to its Orange Partner Program. These latest partnerships give Vertafore customers more options to increase their productivity, manage E&O risks, improve client engagement and access specialized IT support.

Key Points: 
  • With nearly three dozen partners and deep integrations, Vertafore program enables independent agencies, MGAs to customize their InsurTech stacks
    DENVER, March 21, 2022 /PRNewswire/ -- Vertafore , the leader in modern insurance technology, today announced the addition of six solution providers to its Orange Partner Program.
  • The Orange Partner Program includes technology partners with solutions that integrate with Vertafore products, as well as professional services partners that provide service offerings to complement the tools Vertafore customers use every day.
  • "Through the Orange Partner Program, Vertafore enables agencies like mine to integrate with industry-leading InsurTech solutions that are vetted and trustworthy," said Dean Giem, president of Paradox Insurance Agency and board chairman of the Network of Vertafore Users (NetVU).
  • 2022 Vertafore and the Vertafore logo are registered trademarks of Vertafore.

Leo Acquisitions Enters into Binding Letter of Intent for Qualifying Transaction with PsyBio Therapeutics

Retrieved on: 
Monday, October 5, 2020
Economy of Toronto, Corporate finance, Intention, Letter of intent, Mergers and acquisitions, Toronto Stock Exchange, Lioré et Olivier, Economy, Articles, Business

TORONTO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (Leo or the Company) and PsyBio Therapeutics, Inc. (PsyBio) are pleased to announce that they have entered into a binding letter of intent dated October 5, 2020, pursuant to which Leo and PsyBio intend to complete a business combination or other similarly structured transaction which will constitute a reverse take-over of Leo (the Transaction).

Key Points: 
  • TORONTO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (Leo or the Company) and PsyBio Therapeutics, Inc. (PsyBio) are pleased to announce that they have entered into a binding letter of intent dated October 5, 2020, pursuant to which Leo and PsyBio intend to complete a business combination or other similarly structured transaction which will constitute a reverse take-over of Leo (the Transaction).
  • It is intended that the Transaction will be an arms length Qualifying Transaction for Leo, as such term is defined in Policy 2.4 of the Corporate Finance Manual of the TSX Venture Exchange (the TSXV).
  • PsyBio is a US-basedbiotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders.
  • There are no relationships between any non-arms length party of Leo and PsyBio or its assets and the Transaction will be an arms length transaction.